Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03178786 · ClinicalTrials.gov registry record · NA

Visual Spatial Exploration and Art Therapy Intervention in Patients Diagnosed With Parkinson's Disease

A NA study of Parkinson Disease, sponsored by NYU Langone Health.

Completed
Registry status
NA
Development phase
72
Enrollment target
1
Study location

NCT03178786 is a NA study of Parkinson Disease that has completed, run by NYU Langone Health. The registered enrollment target is 72 participants, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03178786, a NA study of Parkinson Disease, has completed, sponsored by NYU Langone Health.

COMPLETED
Registry status
NA
Development phase
72 participants
Enrollment target
1
Study location

Study Summary

The purpose of this dual phase cross-sectional, controlled and prospective, open label, exploratory study is to determine the general characteristics of visuospatial exploration and its neural substrate in subjects with Parkinson's Disease (PD) and to explore the impact of professional art therapy intervention in a cohort of subjects with Parkinson's Disease on visuospatial exploration, visuomotor integration, neuropsychological and emotional sphere, quality of daily living and motor symptoms.

Conditions Studied

Interventions

  • BEHAVIORAL PAT sessions

Study Locations (1)

New York

  • New York University School of Medicine - New York

Trial Details

FieldValue
Enrollment Target 72 participants
Start Date 2017-07-18
Est. Completion 2020-08-10
Phase NA

Sponsor

NYU Langone Health

1,164 total trials

What the Registry Record Tells You About NCT03178786

The ClinicalTrials.gov registry entry for NCT03178786 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (99% lower). The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Parkinson Disease appearing as the primary indexed condition, and to 1 intervention - of which PAT sessions is the first listed.

NCT03178786 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT03178786 about?

NCT03178786 is a clinical study titled "Visual Spatial Exploration and Art Therapy Intervention in Patients Diagnosed With Parkinson's Disease". The purpose of this dual phase cross-sectional, controlled and prospective, open label, exploratory study is to determine the general characteristics of visuospatial exploration and its neural substrate in subjects with Parkinson's Disease (PD) and to explore the impact of professional art therapy i...

What is the current status of trial NCT03178786?

This trial is currently completed. It is a NA study. The enrollment target is 72 participants. The study started on 2017-07-18. Estimated completion is 2020-08-10.

What conditions does trial NCT03178786 study?

This clinical trial studies the following conditions: Parkinson Disease.

What interventions are being tested in trial NCT03178786?

The interventions under investigation include: PAT sessions (BEHAVIORAL).

Who is sponsoring clinical trial NCT03178786?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03178786 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Parkinson Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.